Hypoxia-Induced Drug Resistance in Cancer Cells
Author Information
Author(s): K. Sakata, T. Tak Kwok, B.J. Murphy, K.R. Laderoute, G.R. Gordon, R.M. Sutherland
Primary Institution: SRI International
Hypothesis
Does hypoxia induce drug resistance in cancer cells differently than P-glycoprotein-associated drug resistance?
Conclusion
Hypoxia-induced drug resistance is distinct from P-glycoprotein-associated multidrug resistance.
Supporting Evidence
- Cells exposed to hypoxia developed resistance to adriamycin, 5-fluorouracil, and actinomycin D.
- Resistance to drugs was lost when cells were returned to normal oxygen levels.
- There was no correlation between adriamycin content and the development of adriamycin resistance.
- P-glycoprotein mRNA was not detected in hypoxia-treated cells.
Takeaway
When cancer cells are low on oxygen, they can become resistant to some cancer drugs, but this is different from how some cells resist drugs due to a protein called P-glycoprotein.
Methodology
The study involved exposing EMT6/Ro mammary tumor cells to various drugs after hypoxic treatment and comparing their resistance to that of cells with P-glycoprotein-associated resistance.
Limitations
The study primarily focused on one cell line and specific drugs, which may limit the generalizability of the findings.
Want to read the original?
Access the complete publication on the publisher's website